Copy and paste this code to insert a reference to this article in your
blog or online community profile:
Comprehensive Statistical Analysis of the Pharmacokinetics, Safety and Clinical Benefit Rate of Mitotam in a Single-Center Phase I/Ib Trial in Patients with Metastatic Solid Tumors
Diagnos Pathol Open. 9:3, (0)
https://doi.org/10.4172/2476-2024.1000237
Highlight
Will Display Like this:
Comprehensive Statistical Analysis of the Pharmacokinetics, Safety and Clinical Benefit Rate of Mitotam in a Single-Center Phase I/Ib Trial in Patients with Metastatic Solid Tumors
Diagnos Pathol Open. 9:3, (0)
https://doi.org/10.4172/2476-2024.1000237
Powered by
OMICS International